Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Impax Laboratories, Inc. (delisted) (IPXL)
Impax Laboratories, Inc. (delisted) (IPXL) Actualités

IPXL

Impax Laboratories, Inc. (delisted) (IPXL)

Impax Laboratories, Inc. (delisted)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:IPXL

1 2 3 4 5 6 7 8 9 10 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
14/02/2019	22h00	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
12/02/2019	15h47	Edgar (US Regulatory)	Schedule 13g	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
07/06/2018	22h35	Edgar (US Regulatory)	Amended Tender Offer Statement by Issuer (sc To-i/a)	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
10/05/2018	22h20	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
08/05/2018	22h39	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
07/05/2018	15h11	Edgar (US Regulatory)	Tender Offer Statement by Issuer (sc To-i)	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
07/05/2018	14h30	PR Newswire (US)	ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
07/05/2018	14h28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
07/05/2018	12h00	PR Newswire (US)	Amneal and Impax Complete Business Combination	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
04/05/2018	23h05	Edgar (US Regulatory)	(25-NSE)	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
03/05/2018	00h19	PR Newswire (US)	Apergy Set to Join S&P MidCap 400; 3D Systems to Join S&P SmallCap 600	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
28/04/2018	00h50	PR Newswire (US)	Amneal And Impax Receive FTC Clearance For Business Combination	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
28/04/2018	00h30	PR Newswire (US)	ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/Impax	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
13/04/2018	23h04	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
06/04/2018	13h33	PR Newswire (US)	Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%)	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
05/04/2018	23h24	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
27/03/2018	22h05	PR Newswire (US)	Impax Shareholders Approve Proposed Business Combination with Amneal	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
20/03/2018	11h04	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
14/03/2018	13h00	PR Newswire (US)	Amneal Gains Approval for Erythromycin Tablets USP	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
07/03/2018	14h35	PR Newswire (US)	Amneal Pharmaceuticals and Impax Laboratories to Present at the Barclays Global Healthcare Conference	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
01/03/2018	23h05	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
01/03/2018	13h30	PR Newswire (US)	Amneal Launches Generic for Tamiflu® Oral Suspension	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
01/03/2018	13h00	PR Newswire (US)	Impax Reports Fourth Quarter and Full Year 2017 Results	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
21/02/2018	13h51	PR Newswire (US)	Amneal Introduces Memantine Hydrochloride Extended-Release Capsules, Generic for Namenda XR®	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
20/02/2018	22h05	PR Newswire (US)	Impax Announces the Launch of an Authorized Generic Version of Solodyn® (Minocycline HCl) Extended-Release Tablets	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
12/02/2018	22h49	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (defm14a)	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
12/02/2018	19h17	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
06/02/2018	13h30	PR Newswire (US)	Andrew S. Boyer Joins Amneal Pharmaceuticals as Executive Vice President, Commercial Operations	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
05/02/2018	13h00	PR Newswire (US)	Amneal Launches Methylphenidate Hydrochloride Extended-Release Tablets, USP (CII) AB-Rated Generic for Concerta®	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)
01/02/2018	14h55	PR Newswire (US)	Amneal Introduces Isotretinoin Capsules, USP	NASDAQ:IPXL	Impax Laboratories, Inc. (delisted)

Showing the most relevant articles for your search:NASDAQ:IPXL

1 2 3 4 5 6 7 8 9 10 Suivant >>

Vivat 2.375% 17may2024

ISE Revere Natural Gas TR

Sonoro Gold (QB)

Credit Agricole Consumer...

Amundi Luxembourg

Petroleos Mexicanos

Euronext G Societe Gener...

Keller Manufacturing (PK)

Credit Agricole Assuranc...

Crelan 2.5% Fixed to Flo...

NLBNPIT1XDH2 20250620 34...

Caen The Sea 0.7475% 05/...

Alliance Aviation Services

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales